“Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism”. Metabolism42 (11): 1448–60. (November 1993). doi:10.1016/0026-0495(93)90198-W. PMID7694037.
“Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia”. Biological Psychiatry60 (6): 645–9. (September 2006). doi:10.1016/j.biopsych.2006.04.005. PMID16780811.
“Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia”. Biological Psychiatry55 (5): 452–6. (March 2004). doi:10.1016/j.biopsych.2003.09.012. PMID15023571.
“Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study”. Biological psychiatry63 (1). (2008). doi:10.1016/j.biopsych.2007.04.038. PMID17659263.
nih.gov
pubmed.ncbi.nlm.nih.gov
“Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism”. Metabolism42 (11): 1448–60. (November 1993). doi:10.1016/0026-0495(93)90198-W. PMID7694037.
“Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia”. Biological Psychiatry60 (6): 645–9. (September 2006). doi:10.1016/j.biopsych.2006.04.005. PMID16780811.
“Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia”. Biological Psychiatry55 (5): 452–6. (March 2004). doi:10.1016/j.biopsych.2003.09.012. PMID15023571.
“Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study”. Biological psychiatry63 (1). (2008). doi:10.1016/j.biopsych.2007.04.038. PMID17659263.